Success Metrics

Active Trials
2(40%)

Phase Distribution

Ph phase_2
2
40%
Ph phase_4
3
60%

Phase Distribution

0

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 4Post-market surveillance
3(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Terminated(2)
Other(1)

Detailed Status

Withdrawn2
Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 22 (40.0%)
Phase 43 (60.0%)

Trials by Status

unknown120%
withdrawn240%
recruiting240%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
DRUG
Total Trials
5